Lucid Diagnostics Inc. (LUCD)
NASDAQ:LUCD
Earnings Data
Report Date
May 18, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.06Last Year’s EPS
-0.16Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a mix of strong commercial and clinical momentum—notably higher test volumes, a VA FSS contract at Medicare-aligned pricing, a large real-world study with excellent operational metrics, and advancing payer engagements—balanced against meaningful near-term financial and reimbursement risks. The company has demonstrated product/market fit and payer traction, but current revenue recognition limitations, claim adjudication challenges, a high cash burn rate, and dependence on the timing of Medicare’s LCD materially constrain near-term cash flow and ability to scale until coverage is finalized.Company Guidance
Strong Q4 Test Volume Growth
EsoGuard test volume in Q4 was 3,664 tests, exceeding the company's 2,500–3,000 target range and representing a ~29% increase versus the prior period; management indicated this may represent a new, higher run rate driven by improved field productivity and targeting.
Revenue and Billable Value
Recognized revenue for Q4 was $1,500,000 (≈17% of the quarter's billable value), and the quarter had a billable value of approximately $9,000,000, with recognized revenue up ~24% versus the comparable prior period.
VA Federal Supply Schedule Contract
Awarded a U.S. Department of Veterans Affairs FSS contract for EsoGuard, with pricing aligned to the Medicare rate ($938), giving access to a network of 170 VA medical centers and ~9,000,000 enrolled veterans—positioned as a major commercial opportunity.
Large Real-World Study Validating Product
Published positive data (manuscript in peer-review) from the largest reported real-world esophageal precancer testing experience (~12,000 HET BRICK patients): EsoCheck technical success 95%, 95% of procedures completed in under two minutes, and 100% safety—supporting scalability and payer discussions.
Progress with Major Payers and LBMs
Notable commercial progress: UnitedHealthcare included EsoGuard as an appropriate indicator for EGD within endoscopy guidelines (credentialing initiated), positive engagements with Cigna/Anthem/BCBSA, and an upcoming announcement of the company's first LBM positive coverage policy.
Improved Non-GAAP Per-Share Results
Non-GAAP net loss per share improved materially year-over-year: $0.10 in Q4 and $0.43 for the full year, noted as roughly half the prior year rate—reflecting operating leverage despite investments.
Cash Position and Discipline
Cash at year-end was $34.7 million and management emphasized disciplined reallocation of existing commercial resources (no headcount expansion) while preparing to scale once reimbursement clarity is achieved.
LUCD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LUCD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $1.04 | $1.11 | +6.73% |
Aug 13, 2025 | $1.00 | $0.98 | -2.00% |
May 14, 2025 | $1.19 | $1.28 | +7.56% |
Mar 24, 2025 | $1.52 | $1.50 | -1.32% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lucid Diagnostics Inc. (LUCD) report earnings?
Lucid Diagnostics Inc. (LUCD) is schdueled to report earning on May 18, 2026, After Close (Confirmed).
What is Lucid Diagnostics Inc. (LUCD) earnings time?
Lucid Diagnostics Inc. (LUCD) earnings time is at May 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LUCD EPS forecast?
LUCD EPS forecast for the fiscal quarter 2026 (Q1) is -0.06.